文献速递脑血管病

缺血性卒中或TIA后经皮卵圆孔未闭封堵术的安全性结局

Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.
PubMed 文献 · Stroke · 2017-09-22

该回顾性队列研究利用2005至2013年纽约、加利福尼亚和佛罗里达三州行政索赔住院数据,识别出1887例在缺血性卒中或TIA后1年内接受经皮卵圆孔未闭封堵术的患者。封堵术住院期间任何不良结局的发生率为7.0%(95%CI 5.9%-8.2%),年龄>60岁者和前驱缺血性卒中者发生率更高。

要点

  • 封堵术住院期间任何不良结局发生率为7.0%(95%CI 5.9%-8.2%)。
  • 年龄>60岁者不良结局发生率为10.9%,高于≤60岁者的4.9%。
  • 前驱缺血性卒中者不良结局发生率为9.9%,高于TIA者的5.9%。

核心结论

  • 约每14例在缺血性卒中或TIA后接受经皮卵圆孔未闭封堵术的患者中,有1例发生严重围手术期不良结局或死亡。
  • 不良结局风险在年龄较大的患者和前驱为缺血性卒中的患者中最高。

研究设计与样本

  • 采用行政索赔数据的回顾性队列研究,覆盖2005至2013年纽约、加利福尼亚和佛罗里达三州所有住院记录。
  • 通过ICD-9-CM编码识别在缺血性卒中或TIA后1年内接受经皮卵圆孔未闭封堵术的患者,共1887例。
  • 结局定义为封堵术住院期间发生的不良事件,包括心房颤动或扑动、心脏压塞、气胸、血胸、血管通路并发症或死亡。

主要发现

  • 封堵术住院期间任何不良结局的发生率为7.0%(95%CI 5.9%-8.2%)。
  • 年龄>60岁患者不良结局发生率为10.9%(95%CI 8.6%-13.6%),≤60岁患者为4.9%(95%CI 3.8%-6.3%)。
  • 前驱缺血性卒中患者不良结局发生率为9.9%(95%CI 7.3%-12.5%),前驱TIA患者为5.9%(95%CI 4.7%-7.1%)。

临床怎么用

  • 对缺血性卒中或TIA后拟行经皮卵圆孔未闭封堵术的患者,应告知围手术期不良结局风险约为7.0%。
  • 对年龄>60岁或前驱事件为缺血性卒中的患者,围手术期风险评估应更高。

局限性

  • 研究基于行政索赔数据,依赖ICD-9-CM编码识别患者和结局,可能存在编码偏倚。
  • 数据仅来自纽约、加利福尼亚和佛罗里达三州,外推性有限。
  • 为回顾性观察性设计,无法排除混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: We sought to evaluate the real-world rate of safety outcomes after patent foramen ovale (PFO) closure in patients with ischemic stroke or transient ischemic attack (TIA). METHODS: We performed a retrospective cohort study using administrative claims data on all hospitalizations from 2005 to 2013 in New York, California, and Florida. Using International Classification of Diseases, Ninth Revision, Clinical Modification codes, we identified patients who underwent percutaneous transcatheter PFO closure within 1 year of ischemic stroke or TIA. Our outcome was an adverse event occurring during the hospitalization for PFO closure, defined as in prior studies as atrial fibrillation or flutter, cardiac tamponade, pneumothorax, hemothorax, a vascular access complication, or death. Crude rates were reported with exact confidence intervals. RESULTS: We identified 1887 patients who underwent PFO closure after ischemic stroke or TIA. The rate of any adverse outcome during the hospitalization for PFO closure was 7.0% (95% confidence interval [CI], 5.9%-8.2%). Rates of adverse outcomes varied by age and type of preceding cerebrovascular event. In patients >60 years of age, the rate of adverse outcomes was 10.9% (95% CI, 8.6%-13.6%) versus 4.9% (95% CI, 3.8%-6.3%) in patients ≤60 years of age. The rate of adverse outcomes was 9.9% (95% CI, 7.3%-12.5%) in patients with preceding ischemic stroke versus 5.9% (95% CI, 4.7%-7.1%) after TIA. CONCLUSIONS: Approximately 1 in 14 patients who underwent percutaneous transcatheter PFO closure after ischemic stroke or TIA experienced a serious periprocedural adverse outcome or death. The risk of adverse outcomes was highest in older patients and in those with preceding ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Merkler AE, Gialdini G, Yaghi S, et al. Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale. Stroke. 2017. PMID: 28939677. doi:10.1161/STROKEAHA.117.018501

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。